Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,864,585
-$5,131,331 QoQ
Shares Held
1,486,022
-21.7% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#43
of 640 holders
Holding Since
Sep 2022
14 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $28,929,984 across 5 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (47.9% of the industry book) .
All Filings in HLN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,864,585 | 1,486,022 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $18,995,916 | 1,897,694 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,158,711 | 1,598,290 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,972,885 | 888,839 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,142,918 | 785,238 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,673,532 | 454,182 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,743,581 | 392,409 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $869,834 | 82,215 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $318,076 | 38,508 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $242,253 | 28,534 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $23,990 | 2,915 | Shares | Sole | 2024-02-13 | |
| 2023-03-31 | $7,272,276 | 893,400 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,341,600 | 1,042,700 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,346,455 | 549,500 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||